Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting females, characterized by intellectual disability and autistic behaviors.
• A hallmark symptom of RTT is repetitive hand movements, such as wringing or twisting.
• Recent research identified mutations in the methyl-CpG-binding protein 2 (MECP2) gene as the cause of RTT.

Purpose of the Study:

• To investigate the role of MECP2 gene mutations in the pathogenesis of Rett syndrome.
• To explore the correlation between MECP2 mutation types and phenotypic severity in RTT patients.
• To assess the potential of MECP2 mutation analysis in diagnosing unexplained learning disabilities and neonatal encephalopathies.

Main Methods:

• Molecular studies were conducted to identify MECP2 gene mutations in patients with classic RTT.
• Analysis of mutation types and X-chromosome inactivation patterns in relation to RTT phenotypes.
• Review of clinical data for male patients with severe neonatal encephalopathy linked to MECP2 mutations.

Main Results:

• MECP2 mutations were identified in up to 80% of classic RTT cases.
• Phenotypic severity is influenced by both MECP2 mutation type and X-chromosome inactivation patterns.
• MECP2 mutations can lead to a spectrum of phenotypes beyond classic RTT, including severe neonatal encephalopathy.

Conclusions:

• MECP2 gene mutations are the primary cause of Rett syndrome and associated neurodevelopmental disorders.
• Understanding MECP2 mutations and X-inactivation patterns is crucial for diagnosing and understanding RTT.
• The discovery of MECP2's role broadens diagnostic possibilities for unexplained neurological conditions.